The DOI matches its Crossref record.
Plasma 1,25-Dihydroxy- and 25-Hydroxyvitamin D and Subsequent Risk of Prostate Cancer
Open accessAbstract
AbstractObjective: The hormone 1,25-dihydroxyvitamin D (1,25(OH)2D) promotes prostate epithelial cell differentiation in vitro and thus, several groups have hypothesized that men who systemically have lower levels of 1,25(OH)2D may be at increased risk for prostate cancer. To address this hypothesis, we evaluated the association of circulating concentrations of 1,25(OH)2D and its precursor 25-hydroxyvitamin D (25(OH)D) with subsequent risk of prostate cancer. Methods: Prostate cancer cases were 460 men in the Health Professionals Follow-up Study who were diagnosed through 1998 after providing a blood specimen in 1993/95. 90.2% of the cases were organ confined or had minimal extraprostatic extension. An equal number of controls who had had a screening PSA test after blood draw were individually matched to cases on age, history of a PSA test before blood draw, and time of day, season, and year of blood draw. Plasma 1,25(OH)2D and 25(OH)D concentrations were determined by radio-immunosorbant assay blindly to case–control status. Odds ratios (OR) of prostate cancer and 95% confidence intervals (CI) were estimated from conditional logistic regression models mutually adjusting for quartiles of 1,25(OH)2D and 25(OH)D concentrations and for suspected prostate cancer risk factors. Quartile cutpoints were determined separately by season of blood draw using the distributions among controls. Results: Mean concentrations of 1,25(OH)2D and 25(OH)D were slightly, but not statistically significantly (p= 0.06 and 0.20, respectively), higher in cases (34.3 ± 7.1 pg/ml and 24.6 ± 7.7 ng/ml, respectively) than in controls (33.5 ± 7.1 pg/ml and 23.9 ± 8.2 ng/ml, respectively). The OR of prostate cancer comparing men in the top to bottom quartile of 1,25(OH)2D was 1.25 (95% CI: 0.82–1.90, p-trend = 0.16). For 25(OH)D the OR of prostate cancer comparing the top and bottom quartiles was 1.19 (95% CI: 0.79–1.79, p-trend = 0.59). These findings did not vary by level of the other metabolite, age at diagnosis, family history of prostate cancer, or factors that are thought to influence 25(OH)D levels. Conclusion: In this prospective study, we did not observe an inverse association between plasma concentrations of 1,25(OH)2D or 25(OH)D and incident prostate cancer, although we cannot rule out potential effects at later stages of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
Bouillon, R., Carmeliet, G., Verlinden, L., van Etten, E., Verstuyf, A., Luderer, H. F., Lieben, L., Mathieu, C., & Demay, M. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0004 · Cited by 1,783
25-Hydroxyvitamin D and Risk of Myocardial Infarction in Men<subtitle>A Prospective Study</subtitle>
Giovannucci, E. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.11.1174 · Cited by 1,141
Self-citationProspective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men
Giovannucci, E., Liu, Y., Rimm, E. B., Hollis, B. W., Fuchs, C. S., Stampfer, M. J., & Willett, W. C. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj101 · Cited by 1,046
Self-citationThe Role of Vitamin D in Cancer Prevention
Garland, C. F., Garland, F. C., Gorham, E. D., Lipkin, M., Newmark, H., Mohr, S. B., & Holick, M. F. (2006) · American Journal of Public Health · doi:10.2105/ajph.2004.045260 · Cited by 1,031
Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension
Forman, J. P., Giovannucci, E., Holmes, M. D., Bischoff-Ferrari, H. A., Tworoger, S. S., Willett, W. C., & Curhan, G. C. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.087288 · Cited by 898
Self-citationGenome-wide association study of circulating vitamin D levels
Ahn, J., Yu, K., Stolzenberg-Solomon, R., Simon, K. C., McCullough, M. L., Gallicchio, L., Jacobs, E. J., Ascherio, A., Helzlsouer, K., Jacobs, K. B., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq155 · Cited by 810
The Epidemiology of Prostate Cancer
Pernar, C. H., Ebot, E. M., Wilson, K. M., & Mucci, L. A. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030361 · Cited by 773
The epidemiology of vitamin D and cancer incidence and mortality: A review (United States)
Giovannucci, E. (2005) · Cancer Causes & Control · doi:10.1007/s10552-004-1661-4 · Cited by 598
Self-citationGandini, S., Boniol, M., Haukka, J., Byrnes, G., Cox, B., Sneyd, M. J., Mullie, P., & Autier, P. (2011) · International Journal of Cancer · doi:10.1002/ijc.25439 · Cited by 499
Vitamin D for Cancer Prevention: Global Perspective
Garland, C. F., Gorham, E. D., Mohr, S. B., & Garland, F. C. (2009) · Annals of Epidemiology · doi:10.1016/j.annepidem.2009.03.021 · Cited by 438
Chung, M., Lee, J., Terasawa, T., Lau, J., & Trikalinos, T. A. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-12-201112200-00005 · Cited by 415
Zittermann, A., Iodice, S., Pilz, S., Grant, W. B., Bagnardi, V., & Gandini, S. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.014779 · Cited by 382
Prospective Study of Serum Vitamin D and Cancer Mortality in the United States
Freedman, D. M., Looker, A. C., Chang, S.-C., & Graubard, B. I. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm204 · Cited by 369
Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill*
Braun, A., Chang, D., Mahadevappa, K., Gibbons, F. K., Liu, Y., Giovannucci, E., & Christopher, K. B. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318206ccdf · Cited by 349
Self-citationSerum Vitamin D and the Risk of Parkinson Disease
Knekt, P., Kilkkinen, A., Rissanen, H., Marniemi, J., Sääksjärvi, K., & Heliövaara, M. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.120 · Cited by 337
Circulating 25-Hydroxyvitamin D Levels and Survival in Patients With Colorectal Cancer
Ng, K., Meyerhardt, J. A., Wu, K., Feskanich, D., Hollis, B. W., Giovannucci, E. L., & Fuchs, C. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.1027 · Cited by 301
Self-citationLi, H., Stampfer, M. J., Hollis, J. B. W., Mucci, L. A., Gaziano, J. M., Hunter, D., Giovannucci, E. L., & Ma, J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040103 · Cited by 290
Self-citationSerum Vitamin D Concentration and Prostate Cancer Risk: A Nested Case-Control Study
Ahn, J., Peters, U., Albanes, D., Purdue, M. P., Abnet, C. C., Chatterjee, N., Horst, R. L., Hollis, B. W., Huang, W.-Y., Shikany, J. M., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn152 · Cited by 282
Self-citationVitamin D Status and the Risk of Cardiovascular Disease Death
Kilkkinen, A., Knekt, P., Aro, A., Rissanen, H., Marniemi, J., Heliovaara, M., Impivaara, O., & Reunanen, A. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp227 · Cited by 274
Plasma vitamin D and mortality in older men: a community-based prospective cohort study
Michaëlsson, K., Baron, J. A., Snellman, G., Gedeborg, R., Byberg, L., Sundström, J., Berglund, L., Ärnlöv, J., Hellman, P., Blomhoff, R., et al. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29749 · Cited by 262
Association between plasma 25‐OH vitamin D and testosterone levels in men
Nimptsch, K., Platz, E. A., Willett, W. C., & Giovannucci, E. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04332.x · Cited by 154
Self-citationVitamin D Status and Cancer Incidence, Survival, and Mortality
Kim, H., & Giovannucci, E. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-46227-7_3 · Cited by 29
Self-citation
Metadata
- Authors
- Platz, E. A., Leitzmann, M. F., Hollis, B. W., Willett, W. C., & Giovannucci, E.
- Venue
- Cancer Causes & Control
- Published
- 2004-04
- Volume
- 15
- Issue
- 3
- Pages
- 255-265
- ISSN
- 0957-5243 (ISSN-L)
- 1573-7225
- OpenAlex
- W2013097711
- Cited by
- 229
- References
- 0
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.